Drug Side Effects
Search
IMPLANT SITE FIBROSIS
IMPLANT SITE FIBROSIS
was reported 502 times
IMPLANT SITE FIBROSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Progestin [EPC]
383
0.0013
1
gamma-Aminobutyric Acid-ergic Agonist [EPC]
8
0.0001
2
Thrombopoietin Receptor Agonist [EPC]
1
0.0001
3
Estrogen [EPC]
12
0.0001
4
Ester Local Anesthetic [EPC]
2
0.0000
5
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
1
0.0000
6
Amide Local Anesthetic [EPC]
3
0.0000
7
Non-Standardized Chemical Allergen [EPC]
2
0.0000
8
Antiarrhythmic [EPC]
2
0.0000
9
Central alpha-2 Adrenergic Agonist [EPC]
1
0.0000
10
Methylxanthine [EPC]
1
0.0000
11
Glycopeptide Antibacterial [EPC]
1
0.0000
12
Arteriolar Vasodilator [EPC]
1
0.0000
13
Catecholamine [EPC]
1
0.0000
14
Central Nervous System Stimulant [EPC]
1
0.0000
15
Serotonin Reuptake Inhibitor [EPC]
1
0.0000
16
Purine Antimetabolite [EPC]
1
0.0000
17
P2Y12 Platelet Inhibitor [EPC]
1
0.0000
18
Aldosterone Antagonist [EPC]
1
0.0000
19
Azole Antifungal [EPC]
1
0.0000
20
Proton Pump Inhibitor [EPC]
3
0.0000
21
Expectorant [EPC]
1
0.0000
22
Thiazide Diuretic [EPC]
1
0.0000
23
Corticosteroid [EPC]
5
0.0000
24
Nonsteroidal Anti-inflammatory Drug [EPC]
5
0.0000
25
Benzodiazepine [EPC]
2
0.0000
26
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
27
Vitamin C [EPC]
1
0.0000
28
Atypical Antipsychotic [EPC]
1
0.0000
29
Platelet Aggregation Inhibitor [EPC]
1
0.0000